Cutivate Adverse Reactions

Post-Marketing Data: Adverse drug reactions (ADRs) are listed as follows by MedDRA system organ class and by frequency. Frequencies are defined as: Very common (≥1/10), common (≥1/100 and <1/10), uncommon (≥1/1,000 and <1/100), rare (≥1/10,000 and <1/1,000) and very rare (<1/10,000), including isolated reports.
Infections and Infestations: Very Rare: Opportunistic infection.
Immune System Disorders: Very Rare: Hypersensitivity.
Endocrine Disorders: Very Rare: Hypothalamic-pituitary-adrenal (HPA) axis suppression: Increased weight/obesity; delayed weight gain/growth retardation in children; cushingoid features (e.g. moon face, central obesity); decreased endogenous cortisol levels; hyperglycaemia/glucosuria; hypertension; osteoporosis; cataract; glaucoma.
Skin and Subcutaneous Tissue Disorders: Common: Pruritus. Uncommon: Local skin burning. Very Rare: Skin-thinning, atrophy, striae, telangiectasias, pigmentation changes, hypertrichosis, allergic contact dermatitis, exacerbation of underlying symptoms, pustular psoriasis, erythema, rash, urticaria.